Literature DB >> 25234444

Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.

Martin Grimm1, Marcel Cetindis, Max Lehmann, Thorsten Biegner, Adelheid Munz, Peter Teriete, Siegmar Reinert.   

Abstract

BACKGROUND: Apoptosis resistance is a crucial factor for the carcinogenesis of oral squamous cell carcinoma (OSCC).
METHODS: Expression of apoptosis resistance-related ATP-binding cassette (ABC) transporter ABCB5 [subfamily B (MDR/TAP) member 5] and DNaseX (Apo10) were analyzed in normal oral mucosa (n = 5), oral precursor lesions (simple hyperplasia, n = 11; squamous intraepithelial neoplasia, SIN I-III, n = 35), and OSCC specimen (n = 42) by immunohistochemistry.
RESULTS: Expression of ABCB5 and Apo10 were significantly increased in the carcinogenesis of OSCC compared with normal tissue. Compared with SIN I-III, ABCB5 expression was significantly decreased in OSCC. Apo10 expression did not significantly differ from OSCC compared with SIN I-III.
CONCLUSIONS: This study provides the first evidence of the expression of ABCB5 and Apo10 in the multi-step carcinogenesis of OSCC. Overcoming drug resistance of ABCB5+ and Apo10+ cells in precursor lesions and tumors by natural compounds may act as sensitizers for apoptosis or could be useful for chemoprevention.

Entities:  

Keywords:  ATP-binding cassette (ABC) transporter; DNaseX; apoptosis resistance; early detection and diagnosis; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25234444     DOI: 10.3109/00016357.2014.961029

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  8 in total

1.  Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.

Authors:  Martin Grimm; Wiebke Kraut; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Peter Teriete; Marcel Cetindis; Joachim Polligkeit; Susanne Kluba; Adelheid Munz; Siegmar Reinert
Journal:  Clin Oral Investig       Date:  2015-07-08       Impact factor: 3.573

2.  Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.

Authors:  Martin Grimm; Sebastian Hoefert; Michael Krimmel; Thorsten Biegner; Oliver Feyen; Peter Teriete; Siegmar Reinert
Journal:  Oral Maxillofac Surg       Date:  2016-02-13

3.  Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck.

Authors:  Korinna Jöhrens; Ioannis Anagnostopoulos; Steffen Dommerich; Jan Dirk Raguse; Agnieszka J Szczepek; Frederick Klauschen; Katharina Stölzel
Journal:  Mol Clin Oncol       Date:  2017-02-13

4.  Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.

Authors:  S Saman; M J Stagno; S W Warmann; N P Malek; R R Plentz; E Schmid
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

5.  LINC00963 Promotes Cancer Stemness, Metastasis, and Drug Resistance in Head and Neck Carcinomas via ABCB5 Regulation.

Authors:  Shiao-Pieng Lee; Pei-Ling Hsieh; Chih-Yuan Fang; Pei-Ming Chu; Yi-Wen Liao; Chuan-Hang Yu; Cheng-Chia Yu; Lo-Lin Tsai
Journal:  Cancers (Basel)       Date:  2020-04-26       Impact factor: 6.639

Review 6.  Role of Cell-Free DNA and Deoxyribonucleases in Tumor Progression.

Authors:  Ludmila Alekseeva; Nadezhda Mironova
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma.

Authors:  Cristian Urla; Matias Julian Stagno; Andreas Schmidt; Rupert Handgretinger; Jörg Fuchs; Steven W Warmann; Evi Schmid
Journal:  Biomedicines       Date:  2022-07-28

8.  Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma-a pilot study.

Authors:  Matias J Stagno; Andreas Schmidt; Steven W Warmann; Evi Schmid; Jonas Bochem; Cristian Urla; Rupert Handgretinger; Karin M Cabanillas Stanchi; Rafael Saup; Manon Queudeville; Jörg Fuchs
Journal:  Br J Cancer       Date:  2022-07-21       Impact factor: 9.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.